Net sales decreased by 5% in the third quarter and amounted to 6.8 MSEK (7.2). After three quarters,
The third quarter in review
- Net sales decreased by 5% to 6.8 MSEK (7.2)
- Order intake decreased by 77% to 2.8 MSEK (12.0).
- Order backlog amounted to 11.5 MSEK at the end of the period.
- Bank deposits amounted to 25.6 MSEK at the end of the period.
We continue to believe the market will gradually recover in the first half of 2024, and the fundamental and long-term growth potential in the biotech sector continues to be high due to new technology and unmet patient needs. My full attention is now focused on supporting the sales organization in converting promising prospects into orders. At the same time, our CFO,
Bio-Works’ customers continue to give our products and services high marks, which positions us well when the market recovery occurs,” says Royce.
© Modular Finance, source